Skip to main content
. Author manuscript; available in PMC: 2014 Dec 12.
Published in final edited form as: Cell Rep. 2013 Nov 27;5(5):1243–1255. doi: 10.1016/j.celrep.2013.10.046

Figure 6. NPM Is a Potential Target for the Development of Human Skin Cancers.

Figure 6

(A) The graph shows NPM and IKKα levels in human tissue arrays containing skin SCCs, adjacent tissues surrounding SCCs, and hyperplasia of squamous epithelium, detected using immunohistochemical staining with anti-NPM (left) or anti-IKKα antibody (right). Staining was classified as +++, ++, + and −, according to staining intensity.

(B) Human tissue sections from arrays that were immunohistochemically stained with anti-NPM or anti-IKKα antibody. Brown, positive for NPM or IKKα; blue, nuclear counterstaining; epidermis stained as +++; skin SCC stained as −; condyloma stained as −; PC, breast tissue stained with anti-NPM antibody as positive control; NC, breast tissue stained with isotype control antibody as negative control within black lines. Scale bars, 50 μm.